Researchers develop method to generate billions of cDC1 immune cells
Conventional type 1 dendritic cells, known as cDC1 cells, are immune cells that help initiate responses against intracellular…
Blueberries reduced blood vessel inflammation in mice, but only with gut microbes present
Blueberries contain compounds linked to cardiovascular health, but what happens when gut bacteria are removed from the equation?…
Immunotherapy reshapes immune cell interactions in melanoma-affected lymph nodes
A new study from Mayo Clinic suggests checkpoint immunotherapy may reshape the immune environment within lymph nodes after…
Targeting ANO6 protein weakens pancreatic cancer and boosts immunity
Fox Chase Cancer Center researchers identified a potential therapeutic target for pancreatic cancer after showing that tumor growth…
Platelet hyperactivity drives glioblastoma progression and deep vein thrombosis
New Cleveland Clinic research published in Cancer Cell shows that people with glioblastoma have more active platelets, which are…
Blood pressure drug losartan boosts metabolism by stimulating brown fat
Losartan, a drug commonly prescribed for high blood pressure, boosts brown adipose tissue or “brown fat” activity and…
Experimental gene therapy offers non-surgical option for hydrocephalus
Researchers at the University of Cincinnati College of Medicine have published the first proof-of-concept study showing the potential of an experimental…
CHOP researchers link MAP2K4 variants to a neurodevelopmental disorder
Researchers from Children’s Hospital of Philadelphia (CHOP) have discovered the mechanisms of previously unknown changes in a gene…
Gene therapy and special goggles help some blind adults detect objects again
Scientists are testing whether surviving retinal nerve cells, a light-sensitive protein, and specially designed goggles could offer a…
Year-long trial finds NAD-boosting supplement fails to improve early Parkinson’s symptoms
Encouraging results from earlier studies prompted researchers to investigate whether an NAD-boosting supplement could improve Parkinson’s symptoms during…
Triple combination therapy trial for HR+/HER2− breast cancer halts early due to toxicity concerns
HR+/HER2− breast cancer constitutes approximately 65–75% of all breast cancer cases worldwide. Although CDK4/6 inhibitors have substantially extended progression-free survival (PFS), up…
UCLA researchers present new radiation advances at ASTRO 2026
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share new research and clinical trial…